Mike Tindal, PharmD, MBA, BCGP

Director, Medical Market Access
Employee of Sandoz

Poster(s):

• (155) Cost-effectiveness analysis of somapacitan-beco versus somatropin in the treatment of patients with pediatric growth hormone deficiency (GHD) in the United States
  Wednesday, October 29, 2025